Delivery of diagnostic reagents along with the lease of a system for IHC and ISH staining.
Dostawa czynników diagnostycznych wraz z najmem systemu do barwień IHC oraz ISH.
Poland · Warszawa · how to bid here →
Your path to submission
- Deadline: 29 September at 00:00 — 11 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: POL.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (720 awards, most recently August 2026) — the next award is due around September 2026 by that rhythm. The last award went to Medtronic Poland Sp. z o.o..n = 720
- The median procedure drew just one bid (147 procedures with a bid count); 67% ended with a single bidder. Sector: median 3 bids.n = 147
- 13% of the bids received came from small and medium-sized enterprises (20 procedures with a bid mix). Sector: 50%.n = 20
- 60% of this buyer's awards went to companies that had already won here before (883 awards since 2015, spread over 332 companies). 40% went to new names.n = 883 awards since 2015
- 2% of awards went to companies from abroad (883 awards with a known winner country). Sector average: 4%.n = 883
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 16/09/2026.
Foreign bidders
In Poland · Medical equipment & pharma, 5,178 contracts went to foreign companies over the last 3 years (of 274,171 recorded awards) — mostly from Germany, France, Czechia.
Typical field: median 4 (from 59 awards).
What the buyer is looking for
The summary in English is being prepared. The official description below is in the original language (DE).
Show original description (DE)
Przedmiotem zamówienia jest dostawa czynników diagnostycznych wraz z najmem systemu do barwień IHC oraz ISH: I.Przeciwciała pierwotne, sondy genomowe: /1. BRAF V600E (VE1) MM PAB, op. 1, /2. CD117(EP10) Rabbit Monoclonal PAB, op. 2, /3.CINtec anti-p16 Histology (E6H4),op. 2, /4. anti-ALK-1 (ALK-01), op. 1, /5. anti-CD15 (MMA), op. 2, /6. anti-CD20 (L26), op. 7, /7. anti-CD3 (2GV6), op. 5, /8.anti-CD34 (QBEnd/10), op. 2, /9. anti-CD45 (LCA) (RP2/18), op. 2, /10. anti-CD5 (SP19), op. 3, /11. anti-CD99 (O13), op. 1,/12. anti-Calretinin (SP65), op. 8, /13. anti-Cytokeratin 20 (SP33), op. 5, /14. anti-Cytokeratin 7 (SP52), op. 5, /15. anti-Desmin (DE-R-11), op. 2, /16. anti-EMA (E29), op. 8, /17. anti-ER (SP1), op. 7, /18. anti-Kappa (polyclonal), op. 1, /19. anti-Ki-67 (30-9), op. 20,/20. anti-Lambda (polyclonal), op. 1, /21. nti-MART-1/melan A (A103), op. 1, /22. anti-Melanosome (HMB45), op. 2 /23. anti-PAX5 (SP34), op. 2, /24. anti-PR (1E2), op. 7, /25. anti-PSA (polyclonal), op. 4, /26. anti- S100 (polyclonal), op. 3, /27. anti-Thyroid transcription factor (8G7G3/1), op. 7, /28. anti-Vimentin (V9), op. 2, /29. anti-bcl-2 (SP66), op. 3,/30. Sonda w kierunku wykrywnia wirusa epstein-barra, op. 1, /31. PATHWAY anti-HER-2/neu (4B5), op. 2. /32. PAX8 (EP331) PAb, Cell Marque, op.4, /33. PD-L1 (SP263) CE IVD, op. 50, /34. anti-ALK (D5F3), op. 11, /35. anti-CD10 (SP67), op. 2, /36. anti-CEA (CEA31), op. 2, /37. anti-Chromogranin A (LK2H10), op. 10, /38. anti-Cytokeratin (CAM 5.2), op. 2, /39. anti-Cytokeratin 5&6 (D5/16B4), op. 4 /40. anti-E-Cadherin (36), op. 1 /41.anti-P53 (Bp53-11), op. 2, /42. anti-Pan Keratin (AE1/AE3 & PCK26), op. 9, /43. anti-Actin Smooth Musle (1A4), op. 3, /44. anti-CA 125 (OC125), op. 1, /45. anti-CD138 (B-A38), op. 2, /46. anti-CD163 (MRQ-26), op. 4, /47. anti-CD1a (EP3622), op. 2, /48. anti-CD21 (2G9), op. 2, /49. anti-CD30 (Ber-H2), op. 3, /50. anti-CD31 (JC70), op. 1, /51. anti-CD56 (MRQ-42), op. 10, /52. anti-CDX-2 (EPR2764Y), op. 4, /53. anti-Calcitonin (SP17), op. 1, /54. anti-Caldesmon (E89), op. 1, /55. anti-Calponin-1 (EP798Y), op. 1, /56. anti-Cytokeratin 19 (A53-B/A2.26), op. 1, /57. anti-DOG-1 (SP31), op. 1, /58. anti-Ep-CAM (Ber-EP4), op. 1 /59. anti-Factor VIII R Ag. (polyclonal), op. 1, /60. anti-GATA3 (L50-823), op. 8, /61. anti-GCDFP-15 (EP1582Y), op. 2, /62. nti-GLUT-1 (polyclonal), op. 1, /63. anti-IgG4 (MRQ-44), op. 1, /64. anti-Immunoglobulin G (polyclonal), op. 1, /65. anti-Mammaglobin (31A5), op. 3, /66. anti-Mesothelial Cell (HBME-1), op. 1, /67. anti-Napsin A (MRQ-60), op. 1, /68. anti-PHH3 (polyclonal), op. 2, /69. anti-PSAP (PASE/4LJ), op. 3, /70. anti-Placental Alkaline Phosphatase (NB10), op. 1, /71. anti-Podoplanin (D2-40), op. 3/ 72. anti-Renal Cell Carcinoma (PN-15), op. 1. /73. anti-SALL4 (6E3), op. 1, /74. anti-SOX-10 (SP267), op. 3, /75. anti-Synaptophysin (MRQ-40),op. 15, /76. anti-TTF-1 (SP141), op. 50, /77. anti-Terminal Deoxynucleotidyl Transferase (polyclonal), op. 2, /78. anti-Thyroglobulin (2H11+ 6E1), op. 1, /79. anti-Uroplakin III (SP73), op. 1, /80. anti-WT1 (6F-H2), op. 5, /81. anti-alpha-Fetoprotein (AFP) (polyclonal), op. 1, /82. anti-beta-Catenin (14), op. 1, /83. anti-p40 (BC28),op. 40, /84. anti-ERG (EPR3864),op. 2, /85. anti-Oct-4 (MRQ-10), op. 1, /86. anti-Neuron Specific Enolase (MRQ-55), op.1, /87. anti-Glypican-3 (1G12), op. 1, /88. CMV Blend* (8B1.2, 1G5.2, 2D4.2), op. 1, /89.anti-Hepatocyte Specific Antigen (OCH1E5), op. 1, /90. SATB2 (EP281), op. 3, /91. PRAME Rbt Mono PAB 50 (EPR20330), op. 2, /92. Sonda w kierunku wykrywania lekkich łancuchów kappa i lambda, op. 2, /93. Proteaza 3 do znaczen immunohistochemicznych, op. 1, /94. Proteaza 1 do znaczen immunohistochemicznych, op. 10, /95. Cyclin D1 (SP4-R), op. 2, /96. CD 68 (SP251v18) Rabbit Monoclonal AB, op. 3, /97. CD 79a (SP18), op. 1, /98. INSM1 (SP493) Rabbit Monoclonal Pab, op. 10, /99. MyoD1 (EP212), op. 1, /100. CA IX (EP161) PAb, Cell Marque, op. 1, /101.anti-c-Met (Total) (SP44), op. 1, /1
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in POL.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Urtica Sp.z o.o | 38 | 2021–2026 |
| BIALMED Sp. z o.o. | 29 | 2021–2026 |
| Bialmed Sp. z o.o. | 23 | 2015–2026 |
| Becton Dickinson Polska Sp. z o.o. | 20 | 2021–2026 |
| NEUCA S.A. | 17 | 2021–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on e-Zamówienia (Polen) → Registration, signature, fees — from the operator's bidder manual.